Previous 10 | Next 10 |
2024-03-27 10:24:23 ET More on Medtronic Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now Medtronic plc (MDT) Management presents at 2024 Barclays 26th Annual Healthcare Conference (Transcript) Medtronic: Undervalued Medical Devices Stock With Robust ...
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the sale of the New Zealand oil and gas properties. Pursuant to the terms of the purchase and sale a...
2024-03-20 07:44:44 ET More on the markets SPY: Assessing Economic Risks And Market Trends (Technical Analysis, Rating Downgrade) SPY Is Expensive, But There Are Hiding Places S&P 500: Time To Hedge, Here's How Bull vs. Bear: What’s next for the S&...
Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform. A...
2024-03-07 14:12:00 ET More on Edwards Lifesciences Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained) Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript Edward Lifesciences: Still Not A Buy But Getting Closer ...
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:30 a.m. ET. A live webcast of t...
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to comment on its financial results for the nine months ended December 31, 2023. During the nine months ended December 31, 2023, the Company genera...
2024-02-14 13:27:48 ET Summary Edwards Lifesciences achieved 13% organic revenue growth and received FDA approval for their EVOQUE tricuspid valve replacement system. The company plans to spin off its low-growth Critical Care business to focus on the rapidly expanding structural h...
2024-02-12 16:09:46 ET Despite the challenges posed by COVID-19 and macroeconomic headwinds, the company achieved positive revenue growth in 2023. Net sales increased by $622.4 million compared to the previous year, driven by sales growth of their TAVR products. Although the gross profit incr...
2024-02-06 21:05:23 ET Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Conference Call February 06, 2024, 05:00 PM ET Company Participants Mark Wilterding - Investor Relations and Treasurer Bernard Zovighian - Chief Executive Officer Scott Ullem - Chief Fi...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877)...
Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program wi...
2024-07-08 19:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...